NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 441 / 982

  1. Detection of 30 Fentanyl Analogs by Commercial Immunoassay Kits2020 · OpenAlex
  2. Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing2020 · Crossref
  3. Detection of Embryonic Suspensor Cell Death by Whole-Mount TUNEL Assay in Tobacco2020 · Crossref
  4. Detection of intact insulin analogues in post‐mortem vitreous humour—Application to forensic toxicology casework2020 · Crossref
  5. Detection of Mitragynine in Mitragyna Speciosa (Kratom) Using Surface‐Enhanced Raman Spectroscopy with Handheld Devices2020 · Crossref
  6. Detection of Suicidality Among Opioid Users on Reddit: Machine Learning–Based Approach2020 · OpenAlex
  7. Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings2020 · OpenAlex
  8. Detection of trace drugs of abuse in baby formula using solid‐phase microextraction direct analysis in real‐time mass spectrometry (SPME‐DART‐MS)2020 · OpenAlex
  9. Detection, Identification and Structural Elucidation of Flavonoids using Liquid Chromatography Coupled to Mass Spectrometry2020 · Crossref
  10. Determinants of hookah smoking among men in the coffee houses: an application of socio-ecological approach2020 · Crossref
  11. Determinants of Increased Tobacco Consumption Following a Major Disaster2020 · Crossref
  12. Determinants of prescription opioid use: population‐based evidence from Finland2020 · Crossref
  13. Determinants of Sexual Violence Against Married Women: Qualitative Evidence From Ghana2020 · Crossref
  14. Determinants of Tobacco Smoking Addiction in Rural Indonesian Communities2020 · Crossref
  15. Determinants of Women’s Drug Use During Pregnancy: Perspectives from a Qualitative Study2020 · Crossref
  16. Determination of 30 Synthetic Cathinones in Postmortem Blood Using LC–MS-MS2020 · Crossref
  17. Determination of 37 fentanyl analogues and novel synthetic opioids in hair by UHPLC-MS/MS and its application to authentic cases2020 · OpenAlex
  18. Determination of 4 psychoactive substances in tea using ultra high performance liquid chromatography combined with the quadrupole time-of-flight mass spectrometry2020 · Crossref
  19. Determination of Cannabinoids in Cannabis sativa Dried Flowers and Oils by LC-UV: Single-Laboratory Validation, First Action 2018.102020 · Crossref
  20. Determination of Chlorpromazine Hydrochloride with a Layered Double Hydroxide Modified Glassy Carbon Electrode as a Nanocatalyst2020 · Crossref
  21. Determination of Direct Oral Anticoagulants in Forensic Toxicology2020 · Crossref
  22. Determination of Ethyl Glucuronide and Ethyl Sulfate in Human Whole Blood and Vitreous Humor by LC–MS-MS and Applications to the Interpretation of Postmortem Ethanol Findings2020 · Crossref
  23. Determination of Methomyl Residue in Tobacco Samples by Heart-Cutting Two-Dimensional Liquid Chromatography with Tandem Mass Spectrometry2020 · Crossref
  24. Determination of Morphine, Fentanyl and Their Metabolites in Small Sample Volumes Using Liquid Chromatography Tandem Mass Spectrometry2020 · Crossref
  25. Determination of pentazocine in urine by gas chromatography-mass spectrometry2020 · Crossref
  26. Determination of prescribed and designer benzodiazepines and metabolites in influent wastewater2020 · Crossref
  27. Determination of Specific Absorbance (A¦) for Six Psychoactive Drugs Encountered in Forensic Toxicology2020 · Crossref
  28. Determination of the alcohol biomarker phosphatidylethanol 16:0/18:1 and 33 compounds from eight different drug classes in whole blood by LC-MS/MS2020 · OpenAlex
  29. Determination of the chiral status of different novel psychoactive substance classes by capillary electrophoresis and β‐cyclodextrin derivatives2020 · Crossref
  30. Determination of the stereoisomeric distribution of R-(−)- and S-(+)-methamphetamine in Thai pills in the legal context of “not inconsiderable quantities"2020 · OpenAlex
  31. Determination of the Synthetic Cannabinoids JWH-122, JWH-210, UR-144 in Oral Fluid of Consumers by GC-MS and Quantification of Parent Compounds and Metabolites by UHPLC-MS/MS2020 · OpenAlex
  32. Determinação de cocaína e seus adulterantes empregando Cromatografia Gasosa acoplada à Espectrometria de Massas (GC-MS)2020 · OpenAlex
  33. Determining correlates of the average number of cigarette smoking among college students using count regression models2020 · OpenAlex
  34. Determining Undeclared Synthetic Pharmaceuticals as Adulterants in Weight Loss Herbal Medicines2020 · OpenAlex
  35. Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report2020 · OpenAlex
  36. Developing a Guided Imagery Telephone-Based Tobacco Cessation Program for a Randomized Controlled Trial2020 · Crossref
  37. Developing and Testing the Populi Needle Exchange Point Finder: An App to Reduce Harm Associated With Intravenous Drug Consumption Among Homeless and Non-homeless Drug Users2020 · Crossref
  38. Developing concepts for early mental health prevention and treatment using the built environment2020 · Crossref
  39. Developing interagency collaboration to address the opioid epidemic: A scoping review of joint criminal justice and healthcare initiatives2020 · OpenAlex
  40. Developing logic models to inform public health policy outcome evaluation: an example from tobacco control2020 · Crossref
  41. Developing Production Guidelines for Baby Leaf Hemp (Cannabis sativa L.) as an Edible Salad Green: Cultivar, Sowing Density and Seed Size2020 · Crossref
  42. Development and Feasibility of a Spanish Language Version of the Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use (TAPS) Tool2020 · Crossref
  43. Development and Optimization of a Germination Assay and Long-Term Storage for Cannabis sativa Pollen2020 · Crossref
  44. Development and Pretesting of Hookah Tobacco Public Education Messages for Young Adults2020 · Crossref
  45. Development and validation of a LC-ESI-MS/MS method for simultaneous whole blood analysis of 51 new psychoactive substances2020 · OpenAlex
  46. Development and Validation of a Method for Quantification of 28 Psychotropic Drugs in Postmortem Blood Samples by Modified Micro-QuEChERS and LC–MS-MS2020 · Crossref
  47. Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma2020 · OpenAlex
  48. Development and validation of genetic markers for sex and cannabinoid chemotype in Cannabis sativa L.2020 · OpenAlex
  49. Development and validation of quantitative analytical method for 50 drugs of antidepressants, benzodiazepines and opioids in oral fluid samples by liquid chromatography–tandem mass spectrometry2020 · Crossref
  50. Development and validation of the Capacity to Treat Chronic Pain and Opioid Use Disorder (CAP-POD) questionnaire2020 · Crossref
  51. Development and Validation of the Mukbang Addiction Scale2020 · Crossref
  52. Development and Validation of the Social Network Addiction Scale (SNAddS-6S)2020 · Crossref
  53. Development of a clinical pathway for screening and integrated care of eating disorders in a rural substance use treatment setting2020 · Crossref
  54. Development of a Direct in vitro Plant Regeneration Protocol From Cannabis sativa L. Seedling Explants: Developmental Morphology of Shoot Regeneration and Ploidy Level of Regenerated Plants2020 · OpenAlex
  55. Development of a fast liquid chromatography-tandem mass spectrometry method for simultaneous quantification of neurotransmitters in murine microdialysate2020 · Crossref
  56. Development of a Pencil Drawn Paper‐based Analytical Device to Detect Lysergic Acid Diethylamide (LSD)*†2020 · OpenAlex
  57. Development of a polyvinyl alcohol/sodium alginate hydrogel-based scaffold incorporating bFGF-encapsulated microspheres for accelerated wound healing2020 · OpenAlex
  58. Development of a RP-HPLC Method for Separating and Quantifying Muscimol in Different Developmental Stages of the Fungus Amanita muscaria2020 · OpenAlex
  59. Development of a Training Program for Law Enforcement K9 Handlers to Administer Naloxone2020 · Crossref
  60. Development of a Vaping Machine for the Sampling of THC and CBD Aerosols Generated by Two Portable Dry Herb Cannabis Vaporisers2020 · Crossref
  61. Development of an Electrochemical Method Employing Carbon Screen-Printed Electrodes (C-SPEs) for Detection and Study of MDMA Redox Process2020 · Crossref
  62. Development of an Emergency Department–Based Intervention to Expand Access to Medications for Opioid Use Disorder in a Medicaid Nonexpansion Setting: Protocol for Engagement and Community Collaboration2020 · OpenAlex
  63. Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder2020 · OpenAlex
  64. Development of an Interdisciplinary Telehealth Model of Provider Training and Comprehensive Care for Hepatitis C and Opioid Use Disorder in a High-Burden Region2020 · OpenAlex
  65. Development of Cannabinoids in Flowers of Industrial Hemp (Cannabis sativa L.): A Pilot Study2020 · OpenAlex
  66. Development of extraction technique and GC/FID method for the analysis of cannabinoids in Cannabis sativa L. spp. santicha (hemp)2020 · Crossref
  67. Development of High-Moisture Meat Analogues with Hemp and Soy Protein Using Extrusion Cooking2020 · OpenAlex
  68. Development of Persistent Opioid Use After Cardiac Surgery2020 · OpenAlex
  69. Developmental patterns of tobacco product and cannabis use initiation in high school2020 · Crossref
  70. Developmental trajectories of illicit drug use, prescription drug misuse and cannabis practices among young adult cannabis users in Los Angeles2020 · Crossref
  71. Developmental Trajectories of Tobacco/Nicotine and Cannabis Use and Patterns of Product Co-use in Young Adulthood2020 · Crossref
  72. Developments in Drug Addiction During COVID-19—An Austrian Perspective Based on a Clinical Sample2020 · Crossref
  73. DEVIATIONS OF PATIENTS WITH DRUG ADDICTION VALUE AND MEANING SPHERE FUNCTIONING2020 · Crossref
  74. Dexmedetomidine in Enhanced Recovery After Surgery (ERAS) Protocols for Postoperative Pain2020 · OpenAlex
  75. Dextromethorphan Abuse Among Opioid-Dependent Patients2020 · OpenAlex
  76. DFT calculations as an efficient tool for prediction of Raman and infra-red spectra and activities of newly synthesized cathinones2020 · OpenAlex
  77. DFT study of species derived from the narcotic antagonist naloxone2020 · Crossref
  78. Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder2020 · Crossref
  79. Diagnostic Reliability and Validity of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA) Chinese Version2020 · OpenAlex
  80. Did mass incarceration lead to the disproportionate admission of minorities and marginal offenders?2020 · Crossref
  81. Diet quality, nutrient intakes and biochemical status of New Zealand women of childbearing age according to alcohol consumption patterns2020 · Crossref
  82. Diet, Nutrition and Opioid Addiction2020 · Crossref
  83. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites2020 · OpenAlex
  84. Dietary quality differs among cannabis use groups: data from the National Health and Nutrition Examination Survey 2005–162020 · Crossref
  85. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States2020 · OpenAlex
  86. Differences in length of stay and discharge destination among patients with substance use disorders: The effect of Substance Use Intervention Team (SUIT) consultation service2020 · OpenAlex
  87. Differences in smokers’ awareness of the health risks of smoking before and after introducing pictorial tobacco health warnings: findings from the 2012–2017 international tobacco control (ITC) Netherlands surveys2020 · Crossref
  88. Differences in substance use by sexual orientation and gender among Jewish young adults in Israel2020 · OpenAlex
  89. Different Effects of Cannabis Abuse on Adolescent and Adult Brain2020 · OpenAlex
  90. Different factors predict adolescent substance use versus adult substance abuse: Lessons from a social-developmental approach2020 · Crossref
  91. Differential diagnosis in case of overdose of antiepileptic treatment. Clinical case2020 · Crossref
  92. Differential Diagnosis in Patients with Substance Use Disorder and/or Attention-Deficit/Hyperactivity Disorder Using Continuous Performance Test2020 · Crossref
  93. Differential effects of different antipsychotic drugs on cognitive function in patients with chronic schizophrenia2020 · Crossref
  94. Differential effects of propofol and ketamine on critical brain dynamics2020 · OpenAlex
  95. Differential effects of synthetic psychoactive cathinones and amphetamine stimulants on the gut microbiome in mice2020 · OpenAlex
  96. Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer2020 · Crossref
  97. Differential Responses of Tobacco to the Citrus Variegated Chlorosis and Coffee Stem Atrophy Strains of Xylella fastidiosa2020 · Crossref
  98. Differential sensitivity to detect prosocial effects of 3,4‐methylenedioxymethamphetamine (MDMA) in different social approach paradigms in mice2020 · OpenAlex
  99. Diffusion of Ecstasy in the Electronic Dance Music Scene2020 · OpenAlex
  100. Digital Clinical Trials for Substance Use Disorders in the Age of Covid-192020 · Crossref